Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding
Author:
Affiliation:
1. Department of Medical Research; Digestive Center; E-DA Hospital; Kaohsiung; Taiwan
2. Division of Gastroenterology; Department of Medicine; I-Shou University; Kaohsiung Veterans General Hospital; Kaohsiung; Taiwan
Publisher
Wiley
Subject
Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1746.2012.07244.x/fullpdf
Reference32 articles.
1. Prevention of variceal rebleeding;Bosch;Lancet,2003
2. Prevention of esophageal variceal rebleeding;Loh;J. Chin. Med. Assoc.,2006
3. Management of varices and variceal hemorrhage in cirrhosis;Garcia-Tsao;N. Engl. J. Med.,2010
4. Ligation: endoscopic treatment of choice for patients with bleeding esophageal varices?;Laine;Hepatology,1995
5. A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices;Lo;Hepatology,1995
Cited by 64 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation;Hepatology International;2024-02-28
2. Carvedilol and Traditional Nonselective Beta Blockers for the Secondary Prophylaxis of Variceal Hemorrhage and Portal Hypertension Related Complications Among Patients with Decompensated Cirrhosis: A Systematic Review and Network Meta-Analysis;2024
3. Carvedilol Versus Other Nonselective Beta Blockers for Variceal Bleeding Prophylaxis and Death: A Network Meta-analysis;Journal of Clinical and Translational Hepatology;2023-06-08
4. Comparison of carvedilol and propranolol for primary prophylaxis of esophageal variceal bleed in cirrhotic patients;PAK J PHARM SCI;2023
5. Review article: controversies surrounding the use of carvedilol and other beta blockers in the management of portal hypertension and cirrhosis;Alimentary Pharmacology & Therapeutics;2023-01-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3